Mitchell L. Leibowitz
Impact in
- Aging top 10%
Papers in
-
- CRISPR and Genetic Engineering 3
- Pluripotent Stem Cells Research 2
- Retinal Development and Disorders 2
- Genomics and Phylogenetic Studies 2
- Genetics 5
- Genomic variations and chromosomal abnormalities 3
- Virus-based gene therapy research 2
- Co-authors
- Cheng‐Zhong Zhang (4 shared papers)David Pellman (4 shared papers)Ira M. Hall (3 shared papers)Aaron R. Quinlan (3 shared papers)Stamatis Papathanasiou (2 shared papers)Royden A. Clark (2 shared papers)Phillip A. Doerfler (1 shared paper)Yu Yao (1 shared paper)
- Journals
- Genome Research (2 papers)Nature Communications (1 paper)Experimental & Molecular Medicine (1 paper)Annual Review of Genetics (1 paper)Cell stem cell (1 paper)
- Partner nations
- United StatesCanadaSouth Korea
In The Last Decade
Mitchell L. Leibowitz
9 papers receiving 1.3k citations
Mitchell L. Leibowitz's Hit Papers
Peers
Comparison fields: 5 of 87
- Business and International Management 40
- Aging 31
- Cancer Research 205
- Genetics 390
- Molecular Biology 962
Countries citing papers authored by Mitchell L. Leibowitz
This map shows the geographic impact of Mitchell L. Leibowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell L. Leibowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell L. Leibowitz more than expected).
Fields of papers citing papers by Mitchell L. Leibowitz
This network shows the impact of papers produced by Mitchell L. Leibowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell L. Leibowitz. The network helps show where Mitchell L. Leibowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell L. Leibowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing Hit paper breakdown → | 2021 | 368 |
| 2 | 2010 | 219 | |
| 3 | 2013 | 171 | |
| 4 | 2015 | 148 | |
| 5 | 2013 | 125 | |
| 6 | 2011 | 90 | |
| 7 | 2020 | 85 | |
| 8 | 2021 | 79 | |
| 9 | 2024 | 7 |
About Mitchell L. Leibowitz
Mitchell L. Leibowitz is a scholar working on Molecular Biology, Genetics, Plant Science, Cancer Research and Physiology, having authored 9 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chromosomal and Genetic Variations (4 papers), Genomic variations and chromosomal abnormalities (3 papers), CRISPR and Genetic Engineering (3 papers), Cancer Genomics and Diagnostics (2 papers), Pluripotent Stem Cells Research (2 papers), Retinal Development and Disorders (2 papers), Genomics and Phylogenetic Studies (2 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Business and International Management (40 citations), Aging (31 citations), Cancer Research (205 citations), Genetics (390 citations) and Molecular Biology (962 citations). Mitchell L. Leibowitz has collaborated with scholars based in United States, Canada and South Korea. Frequent co-authors include Cheng‐Zhong Zhang, David Pellman, Ira M. Hall, Aaron R. Quinlan, Stamatis Papathanasiou, Royden A. Clark, Phillip A. Doerfler, Yu Yao, Lili Sun and Mitchell J. Weiss. Their work appears in journals such as Genome Research, Nature Communications, Experimental & Molecular Medicine, Annual Review of Genetics and Cell stem cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.